Sihuan Pharmaceutical Holdings Group Ltd

Common Name
Sihuan Pharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2,667
Ticker
460
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical and medical aesthetic products in ...

Sihuan Pharmaceutical's GHG Emissions Data Preview

In 2023, Sihuan Pharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).

However, Sihuan Pharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Sihuan Pharmaceutical's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Sihuan Pharmaceutical amounted to 104,067.67 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Sihuan Pharmaceutical decreased by 15.59%, showing that the company has made progress in taking action to reduce the climate impact of its operations.

Sihuan Pharmaceutical's Scope 1 Emissions Over Time

202120222023015 k30 k45 k60 ktCO2e+6%-13%
  • Total Scope 1
  • Year-over-Year Change

What are Sihuan Pharmaceutical's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Sihuan Pharmaceutical were 45,601.81 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Has Sihuan Pharmaceutical reduced its Scope 1 emissions over time?

Since 2021, Sihuan Pharmaceutical's Scope 1 emissions have decreased by 7.55%, reflecting a declining long-term trend in Scope 1 emissions over time.

Compared to the previous year (2022), Sihuan Pharmaceutical's Scope 1 emissions decreased by 12.63%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.

What are Sihuan Pharmaceutical's Scope 2 emissions?

In 2023, Sihuan Pharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 58,465.86 tCOâ‚‚e without specifying the calculation method.

Has Sihuan Pharmaceutical reduced its Scope 2 emissions over time?

Since 2021, Sihuan Pharmaceutical's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have decreased by 20.45%, reflecting a declining long-term trend in Scope 2 emissions over time.

Compared to the previous year (2022), Sihuan Pharmaceutical's Scope 2 emissions (Unspecified Calculation Method) fell by 17.77% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.

What methodology does Sihuan Pharmaceutical use for Scope 2 reporting?

In 2023, Sihuan Pharmaceutical reported its Scope 2 emissions using an unspecified methodology.

Sihuan Pharmaceutical's Scope 2 Emissions Over Time

202120222023020 k40 k60 k80 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)